Buscar
Sol Gel Technologies Ltd
SLGLAñadir a la lista de seguimiento
82.250USD
-2.940-3.45%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
268.87MCap. mercado
PérdidaP/E TTM
Más Datos de Sol Gel Technologies Ltd Compañía
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
Información de Sol Gel Technologies Ltd
Símbolo de cotizaciónSLGL
Nombre de la empresaSol Gel Technologies Ltd
Fecha de salida a bolsaFeb 01, 2018
Director ejecutivo- -
Número de empleados34
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 01
DirecciónGolda Meir 7
CiudadNESS-ZIONA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal- -
Teléfono97289313433
Sitio Webhttp://www.sol-gel.com
Símbolo de cotizaciónSLGL
Fecha de salida a bolsaFeb 01, 2018
Director ejecutivo- -
Ejecutivos de Sol Gel Technologies Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Moshe (Mori) Arkin
Mr. Moshe (Mori) Arkin
Executive Chairman of the Board
Executive Chairman of the Board
143.26K
--
Mr. Ran Gottfried
Mr. Ran Gottfried
Lead Independent Director
Lead Independent Director
1.55K
--
Dr. Ofer Toledano, Ph.D.
Dr. Ofer Toledano, Ph.D.
Vice President - Research and Development
Vice President - Research and Development
--
--
Dr. Ofra Levy-Hacham, Ph.D.
Dr. Ofra Levy-Hacham, Ph.D.
Vice President - Clinical and Regulatory Affairs
Vice President - Clinical and Regulatory Affairs
--
--
Dr. Karine Neimann, Ph.D.
Dr. Karine Neimann, Ph.D.
Vice President - Projects and Planning, Chief Chemist
Vice President - Projects and Planning, Chief Chemist
--
--
Dr. Itzik Yosef, Ph.D.
Dr. Itzik Yosef, Ph.D.
Vice President - Operations
Vice President - Operations
--
--
Dr. Dubi (Dov) Zamir, Ph.D.
Dr. Dubi (Dov) Zamir, Ph.D.
Vice President - Special Projects
Vice President - Special Projects
--
--
Mr. Itai Arkin
Mr. Itai Arkin
Director
Director
--
--
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Dr. Shmuel (Muli) Ben Zvi, Ph.D.
Independent Director
Independent Director
--
--
Ms. Hani Lerman
Ms. Hani Lerman
Director
Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Moshe (Mori) Arkin
Mr. Moshe (Mori) Arkin
Executive Chairman of the Board
Executive Chairman of the Board
143.26K
--
Mr. Ran Gottfried
Mr. Ran Gottfried
Lead Independent Director
Lead Independent Director
1.55K
--
Dr. Ofer Toledano, Ph.D.
Dr. Ofer Toledano, Ph.D.
Vice President - Research and Development
Vice President - Research and Development
--
--
Dr. Ofra Levy-Hacham, Ph.D.
Dr. Ofra Levy-Hacham, Ph.D.
Vice President - Clinical and Regulatory Affairs
Vice President - Clinical and Regulatory Affairs
--
--
Dr. Karine Neimann, Ph.D.
Dr. Karine Neimann, Ph.D.
Vice President - Projects and Planning, Chief Chemist
Vice President - Projects and Planning, Chief Chemist
--
--
Dr. Itzik Yosef, Ph.D.
Dr. Itzik Yosef, Ph.D.
Vice President - Operations
Vice President - Operations
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Sol Gel Technologies Ltd?
Los cinco principales accionistas de Sol Gel Technologies Ltd son: Mr. Moshe (Mori) Arkin
¿Cuántas instituciones poseen acciones de Sol Gel Technologies Ltd (SLGL)?
A fecha de 2026Q1, 39 instituciones poseen acciones de Sol Gel Technologies Ltd, con un valor de mercado combinado de aproximadamente 1.00M, lo que representa el 30.93% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -175336.00.